Live Price
Live Volume
Chart Volume 0
Volume 0
5 secEnlivex Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+2.61(+1,602.52%)
| Open | $0.16 |
|---|---|
| Close | $2.77 |
| Low | $0.16 |
| Low Change | 0.00 (0.00%) |
| High | $2.77 |
| High Change | +2.61 (+1,602.52%) |
| Range | $2.61 |
| Volume | 28.965K |
| Dollar Volume | $80.23K |
Regular Trading Hours Yesterday
-0.01(-6.34%)
| Open | $0.17 |
|---|---|
| Close | $0.16 |
| Low | $0.16 |
| Low Change | -0.01 (-7.67%) |
| High | $0.17 |
| High Change | +0.00 (+0.87%) |
| Range | $0.01 |
| Volume | 377.386K |
| Dollar Volume | $61.29K |
Premarket Yesterday
-0.00(-2.27%)
| Open | $0.18 |
|---|---|
| Close | $0.17 |
| Low | $0.17 |
| Low Change | -0.00 (-2.27%) |
| High | $0.19 |
| High Change | +0.01 (+5.22%) |
| Range | $0.01 |
| Volume | 11.109K |
| Dollar Volume | $1.91K |
Enlivex Therapeutics News
There is no current news for this stock at the moment.
Enlivex Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Enlivex Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.19 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.20 |
| 20 Day Moving Average (SMA20) | $0.28 |
| 50 Day Moving Average (SMA50) | $0.78 |
| 100 Day Moving Average (SMA100) | $1.50 |
| 200 Day Moving Average (SMA200) | $1.23 |
Enlivex Therapeutics Statistics
| Average Volume (30 Days) | 1.74M |
|---|---|
| P/E Ratio (Current) | -.60 |
| EPS (Current) | -$0.42 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 1.30 |
| Current Ratio | 8.72 |
| Quick Ratio | 8.72 |
| Debt to Equity | 0.00 |
| Enterprise Value | -$695.85K |
| EV to EBITDA | 0.07 |
| EV to Sales | — |
| Price to Book | 0.14 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.21% |
| Return on Equity | -0.24% |
Enlivex Therapeutics Stock Splits
There have been 3 stock splits for Enlivex Therapeutics (ENLV). The last reverse stock split occured on July 9, 2026 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Jul 9, 2026 | Reverse | 15:1 |
| Mar 6, 2019 | Reverse | 8:1 |
| Sep 25, 2017 | Reverse | 5:1 |
Enlivex Therapeutics Dividends
There have been no dividends for Enlivex Therapeutics (ENLV).